Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
10 06 2022
10 06 2022
Historique:
received:
12
01
2022
accepted:
27
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
15
6
2022
Statut:
epublish
Résumé
Motor-assisted movement exercisers (MME) are devices that assist with physical therapy in domestic settings for people living with ALS. This observational cross-sectional study assesses the subjective experience of the therapy and analyzes users' likelihood of recommending treatment with MME. The study was implemented in ten ALS centers between February 2019 and October 2020, and was coordinated by the research platform Ambulanzpartner. Participants assessed symptom severity, documented frequency of MME use and rated the subjective benefits of therapy on a numerical scale (NRS, 0 to 10 points, with 10 being the highest). The Net Promotor Score (NPS) determined the likelihood of a participant recommending MME. Data for 144 participants were analyzed. Weekly MME use ranged from 1 to 4 times for 41% of participants, 5 to 7 times for 42%, and over 7 times for 17%. Particularly positive results were recorded in the following domains: amplification of a sense of achievement (67%), diminution of the feeling of having rigid limbs (63%), diminution of the feeling of being immobile (61%), improvement of general wellbeing (55%) and reduction of muscle stiffness (52%). Participants with more pronounced self-reported muscle weakness were more likely to note a beneficial effect on the preservation and improvement of muscle strength during MME treatment (p < 0.05). Overall, the NPS for MME was high (+ 61). High-frequency MME-assisted treatment (defined as a minimum of five sessions a week) was administered in the majority of participants (59%) in addition to physical therapy. Most patients reported having achieved their individual therapeutic objectives, as evidenced by a high level of satisfaction with MME therapy. The results bolster the justification for extended MME treatment as part of a holistic approach to ALS care.
Identifiants
pubmed: 35688956
doi: 10.1038/s41598-022-13761-6
pii: 10.1038/s41598-022-13761-6
pmc: PMC9187150
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9657Informations de copyright
© 2022. The Author(s).
Références
Amyotroph Lateral Scler. 2012 Feb;13(2):210-6
pubmed: 22292842
J Spinal Cord Med. 2017 Jan;40(1):8-16
pubmed: 27841091
Int J Geriatr Psychiatry. 2019 Jan;34(1):31-37
pubmed: 30247775
Handb Clin Neurol. 2016;138:225-38
pubmed: 27637961
Neurol Clin. 2015 Nov;33(4):735-48
pubmed: 26515618
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):342-350
pubmed: 29382225
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Neurol. 2021 May;268(5):1857-1866
pubmed: 33388929
JMIR Rehabil Assist Technol. 2018 Nov 12;5(2):e10099
pubmed: 30425026
Brain Res Bull. 2016 Jun;124:144-9
pubmed: 27108543
Eur J Neurol. 2021 Apr;28(4):1160-1171
pubmed: 33210770
J Physiol. 2009 Jul 15;587(Pt 14):3561-72
pubmed: 19491245
JMIR Diabetes. 2017 Nov 01;2(2):e28
pubmed: 30291087
Front Neurol. 2015 Sep 02;6:194
pubmed: 26388836
J Neurol. 2018 Apr;265(4):774-782
pubmed: 29392461
Neurology. 2006 Jan 24;66(2):265-7
pubmed: 16434671
Int J Environ Res Public Health. 2021 Jan 26;18(3):
pubmed: 33530383
Adv Prev Med. 2020 Feb 29;2020:7282013
pubmed: 32181019
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):783-785
pubmed: 32317400
Degener Neurol Neuromuscul Dis. 2018 Jul 16;8:45-54
pubmed: 30890895
Eur J Neurol. 2021 Aug;28(8):2582-2595
pubmed: 33960080
J Neurol Sci. 2007 Feb 15;253(1-2):18-24
pubmed: 17241642
Rev Med Virol. 2022 Apr 13;:e2349
pubmed: 35416354
Physiotherapy. 2021 Dec;113:12-28
pubmed: 34555670
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Mult Scler Relat Disord. 2019 Sep;34:128-134
pubmed: 31260943
Health Expect. 2015 Dec;18(6):3099-109
pubmed: 25345554